on November 15, 2012. To view agenda, click
here The minutes of this meeting show that:
At 11:15 AM Pharmacists Michael Riepl and Kevin Oberlander arrived to discuss the
compounding and sale of Over-the-Counter medications and the labeling required for that sale.
The discussion also included aspects of sterile compounding and consideration of what might
happen relative to the FDA’s increased scrutiny of compounding in light of the New England
Compounding issue.
Pharmacist Riepl distributed a label that he had prepared for one of the Over-the-Counter
products which he has been making and which are in clinical trials with the Mayo Clinic and his
pharmacy.
It was moved by Pharmacist Ziegler and seconded by Pharmacist Thom to table the Over-
The-Counter compounding issue until the January 2013 Board Meeting and invite nonsterile
compounding pharmacists interested in the preparation of Over-the-Counter
products to attend that meeting with specific suggestions for how the Board should regulate
this activity. All Board Members voted aye – the motion carried.
To view the entire minutes click
here